Low density lipoprotein particle size and risk of early-onset myocardial infarction in women

American Journal of Epidemiology

Volumn 153, Issue 10, 2001, Pages 939-945

  Kamigaki, Alisa S ^a,d   Siscovick, David S ^a,b   Schwartz, Stephen M ^a   Psaty, Bruce M ^a,b   Edwards, Karen L ^a   Raghunathan, Trivellore E ^c   Austin, Melissa A ^a,e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Coronary disease; Lipoproteins, HDL; Lipoproteins, LDL; Myocardial infarction; Triglycerides

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; COMORBIDITY; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; PARTICLE SIZE; RISK ASSESSMENT; UNITED STATES;

ADULT; AGE OF ONSET; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; HUMANS; LIPOPROTEINS, LDL; MYOCARDIAL INFARCTION; ODDS RATIO; PARTICLE SIZE; RISK FACTORS;

EID: 0035873686     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/153.10.939     Document Type: Article

References (41)

1. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study
2. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
3. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
4. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)
5. Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the cholesterol and recurrent events trial
6. Lipoprotein changes and reduction in the incidence of major coronary disease events in the Scandinavian Simvastatin Survival Study (4S)
7. Identification of multiple subclasses of plasma low-density lipoprotein in normal humans
8. Heterogeneity of plasma low density lipoproteins manifestations of the physiologic phenomenon in man
9. Studies of low density lipoprotein molecular weight in human beings with coronary artery disease
10. Low-density lipoprotein subclass patterns and risk of myocardial infarction
11. Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction
12. Low density lipoprotein particle size and coronary artery disease
13. Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women
14. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: Relative contribution of small, dense LDL to coronary heart disease risk
15. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction
16. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women
17. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study
18. Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene
19. Use of low-dose oral contraceptives and stroke in young women
20. Myocardial infarction and use of low-dose oral contraceptives: A pooled analysis of 2 US studies
21. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women
22. Thrombosis in the young: Effect of atherosclerotic risk factors on the risk of myocardial infarction associated with prothrombotic factors
23. Risk of stroke in young women and two prothrombotic mutations: Factor V Leiden and prothrombin gene variant (G20210A)
24. Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study
25. Random digit dialing in selecting a population-based control group
26. Enzymatic methods for quantification of lipoprotein lipids
27. Triglyceride, small, dense low-density lipoprotein, and the atherogenic lipoprotein phenotype
28. LDL particle size is a risk factor for coronary heart disease independent of triglyceride and HDL cholesterol: A meta-analysis of three prospective studies in men
29. Low-density lipoprotein particle size, triglycerides, and high-density lipoprotein cholesterol as risk factors for coronary heart disease in older Japanese-American men
30. Atherogenic lipoprotein phenotype: A proposed genetic marker for coronary heart disease risk
31. LDL subclass phenotypes and the insulin resistance syndrome
32. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles
33. Insulin and cardiovascular disease. Paris Prospective Study
34. Plasma HDL cholesterol, triglycerides, and adiposity: A quantitative genetic test of the conjoint trait hypothesis in the San Antonio Family Heart Study
35. Heritability of factors of the insulin resistance syndrome in women twins
36. Pleiotropic genetic effects on LDL size, plasma triglyceride, and HDL cholesterol in families
37. Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and α-tocopherol content
38. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity
39. Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small LDL but not in triglyceride-rich LDL of normal size